Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses

Trial Profile

Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses

Status: Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 19 Nov 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Breast cancer; Carcinoma
  • Focus Pharmacodynamics
  • Most Recent Events

    • 11 Oct 2018 Status changed from recruiting to withdrawn prior to enrolment due to slow accrual.
    • 31 Aug 2018 Biomarkers information updated
    • 12 Dec 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top